{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T13:18:27Z","timestamp":1783430307458,"version":"3.54.6"},"reference-count":24,"publisher":"IMR Press","issue":"6","license":[{"start":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T00:00:00Z","timestamp":1782604800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Internal Research Project of the First Affiliated Hospital of Kunming Medical University","award":["2023LCYXZX003"],"award-info":[{"award-number":["2023LCYXZX003"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmazie"],"abstract":"<jats:p>Background:The post-dispensing process of Pharmacy Intravenous Admixture Services (PIVAS), including verification, packaging, transportation, nurse receipt and verification, and clinical administration, involves multiple high-risk steps associated with intravenous medication safety. However, existing risk management studies have primarily focused on internal preparation procedures within PIVAS, with limited attention to the external circulation processes after admixture preparation.Methods:Failure mode and effects analysis (FMEA) was applied to systematically identify, evaluate, and prioritize potential risks in the post-dispensing workflow of finished intravenous infusions. Risk priority numbers (RPNs) were calculated based on severity, occurrence, and detectability scores. High-risk failure modes were defined as those with an RPN \u2265120 or a severity score \u22658. Targeted corrective interventions were subsequently implemented for these high-risk processes.Results:A total of six high-risk failure modes were identified across the post-dispensing workflow. Following FMEA-based interventions, the total RPN score of these six high-risk failure modes decreased from 707 to 394, representing a 44.3% reduction. In addition, the incidence of real-world risk events decreased significantly between 2020 and 2022 (p &lt; 0.001), indicating substantial improvements in medication safety and process quality.Conclusion:FMEA is an effective and practical tool for extending quality control from internal admixture preparation to the complete post-dispensing process in PIVAS. The implementation of FMEA facilitated the establishment of a closed-loop risk management framework and improved the safety of intravenous medication administration.<\/jats:p>","DOI":"10.31083\/pharmazie52007","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T12:56:33Z","timestamp":1783428993000},"source":"Crossref","is-referenced-by-count":0,"title":["Assessment of the Quality of Finished Intravenous Infusions Using Failure Mode and Effects Analysis"],"prefix":"10.31083","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2654-5423","authenticated-orcid":true,"given":"Yani","family":"Ma","sequence":"first","affiliation":[{"name":"Clinical Pharmacy Center, The First Affiliated Hospital of Kunming Medical University, 650032 Kunming, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8318-797X","authenticated-orcid":true,"given":"Wei","family":"Chen","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Center, The First Affiliated Hospital of Kunming Medical University, 650032 Kunming, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3246-1053","authenticated-orcid":true,"given":"Jirong","family":"Li","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Center, The First Affiliated Hospital of Kunming Medical University, 650032 Kunming, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0956-0517","authenticated-orcid":true,"given":"Yanping","family":"Yang","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Center, The First Affiliated Hospital of Kunming Medical University, 650032 Kunming, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1970-561X","authenticated-orcid":true,"given":"Dangli","family":"Bai","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Center, The First Affiliated Hospital of Kunming Medical University, 650032 Kunming, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8746-1778","authenticated-orcid":true,"given":"Meng","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Yan\u2019an Hospital Affiliated to Kunming Medical University, 650051 Kunming, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6362-5217","authenticated-orcid":true,"given":"Yulian","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Yan\u2019an Hospital Affiliated to Kunming Medical University, 650051 Kunming, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7212-2692","authenticated-orcid":true,"given":"Fangyun","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Yan\u2019an Hospital Affiliated to Kunming Medical University, 650051 Kunming, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,6,28]]},"reference":[{"key":"ref1","unstructured":"Lyu H, Wu Y. Construction and situation of centralized intravenous drug dispensing mode in China. China Pharmacy. 2021; 32: 641\u2013646."},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Xu JJ, Sun CP, Wu Q. Risk management using FMEA to assess PIVAS irrational prescriptions medication. Chinese Journal of Modern Applied Pharmacy. 2018; 35: 1564\u20131568.","DOI":"10.13748\/j.cnki.issn1007-7693.2018.10.030"},{"key":"ref3","unstructured":"Shangguan XF, Ke M, Yang LH, Liu YX, Wang J, Cai YX, et al. Application of failure mode and effect analysis and sociotechnical probabilistic risk assessment in high-risk drugs management. Herald of Medicine. 2020; 39: 1350\u20131355."},{"key":"ref4","unstructured":"Liu LJ, Zhao WJ, Song AM, Li XC, Gao P, Leng P. Application of failure mode and effect analysis in risk management of the entire insulin deployment in PIVAS. Chinese General Practice Nursing. 2025; 23: 2201\u20132206."},{"key":"ref5","unstructured":"Fei W, Han JP, Geng Z, Pan J. Risk assessment and management of noncompliant behaviors in PIVAS admixture based on FMEA. Chinese Journal of Hospital Pharmacy. 2023; 43: 1154\u20131159. (In Chinese)"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Pu JW, Zhang H, Geng Z, Pan J. Application of failure mode and effects analysis method in risk management of the entire process of pharmacy intravenous admixture service antitumor drugs formulation. Chinese Journal of Modern Applied Pharmacy. 2025; 42: 130\u2013136.","DOI":"10.13748\/j.cnki.issn1007-7693.20241738"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Zhang L, He X, Wang Y, Huang L, Du X, Liu M. Using failure mode and effects analysis for risk management of anesthetic and class I psychotropic drugs in inpatient pharmacy: a pilot study. Scientific Reports. 2025; 15: 29613.","DOI":"10.1038\/s41598-025-13377-6"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Anjalee JAL, Rutter V, Samaranayake NR. Application of failure mode and effects analysis (FMEA) to improve medication safety in the dispensing process - a study at a teaching hospital, Sri Lanka. BMC Public Health. 2021; 21: 1430.","DOI":"10.1186\/s12889-021-11369-5"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Liu XX, Liang HX, Wu L, Deng SR, Liang HB, Deng XJ, et al. Reducing the risk of valuable medicines management and use in PIVAS based on healthcare failure mode and effect analysis. Anhui Medical and Pharmaceutical Journal. 2025; 29: 1052\u20131056. doi:","DOI":"10.3969\/j.issn.1009-6469.2025.05.038"},{"key":"ref10","unstructured":"Yuan HL, Wu Q, Wang L. Research on risk management strategy of nosocomial infection in PIVAS based on failure mode and effect analysis. Chinese Journal of Modern Applied Pharmacy. 2022; 39: 684\u2013689."},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Cai J, Li MX, Lu S, Shen D, Xie W, Zhu JJ, et al. Use of failure mode and effect analysis to improve the monoclonal antibody drugs management process in pharmacy intravenous admixture services. Scientific Reports. 2025; 15: 4653.","DOI":"10.1038\/s41598-025-89145-3"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Gillings N, Hjelstuen O, Behe M, Decristoforo C, Elsinga PH, Ferrari V, et al. EANM guideline on quality risk management for radiopharmaceuticals. European journal of nuclear medicine and molecular imaging. 2022; 49: 3353\u20133364.","DOI":"10.1007\/s00259-022-05738-4"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"F\u00e4rlin-Helin A, Suominen S, Tuominen O. Use of Failure Mode and Effect Analysis Methods in Pediatric and Adolescent Hospital Care: A Scoping Review. Journal of Patient Safety. 2025; 21: e74\u2013e89.","DOI":"10.1097\/PTS.0000000000001350"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Ashley L, Armitage G. Failure mode and effects analysis: an empirical comparison of failure mode scoring procedures. Journal of Patient Safety. 2010; 6: 210\u2013215.","DOI":"10.1097\/pts.0b013e3181fc98d7"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"American Society for Healthcare Risk Management. Strategies and tips for maximizing failure mode and effect analysis in an organization. Journal of Healthcare Risk Management : the Journal of the American Society for Healthcare Risk Management. 2002; 22: 9\u201312.","DOI":"10.1002\/jhrm.5600220304"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Yu L, Fu L. Safety Management Model of Pharmacy Intravenous Admixture Services Based on FMEA Principles. Herald of Medicine. 2014; 33: 268\u2013271.","DOI":"10.3870\/yydb.2014.02.041"},{"key":"ref17","unstructured":"Yu R. Application Effects of Detail Management and Process Control in Pharmacy Intravenous Admixture Services\u2014A Review of \"Safe Preparation and Rational Use of PIVAS Finished Infusions\". World Chinese Medicine. 2024; 19: 144."},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Micheletta F, Ferrara M, Bertozzi G, Volonnino G, Nasso M, La Russa R. Proactive Risk Assessment through Failure Mode and Effect Analysis (FMEA) for Perioperative Management Model of Oral Anticoagulant Therapy: A Pilot Project. International Journal of Environmental Research and Public Health. 2022; 19: 16430.","DOI":"10.3390\/ijerph192416430"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"La Russa R, Fazio V, Ferrara M, Di Fazio N, Viola RV, Piras G, et al. Proactive Risk Assessment Through Failure Mode and Effect Analysis (FMEA) for Haemodialysis Facilities: A Pilot Project. Frontiers in Public Health. 2022; 10: 823680.","DOI":"10.3389\/fpubh.2022.823680"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Geramian A, Shahin A, Minaei B, Antony J. Enhanced FMEA: An integrative approach of fuzzy logic-based FMEA and collective process capability analysis. Journal of the Operational Research Society. 2020; 71: 800\u2013812.","DOI":"10.1080\/01605682.2019.1606986"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Altubaishe B, Desai S. Multicriteria Decision Making in Supply Chain Management Using FMEA and Hybrid AHP-PROMETHEE Algorithms. Sensors (Basel, Switzerland). 2023; 23: 4041.","DOI":"10.3390\/s23084041"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Anjalee JAL, Rutter V, Samaranayake NR. Application of Failure Mode and Effect Analysis (FMEA) to improve medication safety: a systematic review. Postgraduate Medical Journal. 2021; 97: 168\u2013174.","DOI":"10.1136\/postgradmedj-2019-137484"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Qiu Q, Zhu G, Peng G, Chen Z, Zhu Z, Zhou Y, et al. Research on PIVAS risk assessment and control strategy based on quality risk management (QRM). Exploratory Research in Clinical and Social Pharmacy. 2024; 15: 100487.","DOI":"10.1016\/j.rcsop.2024.100487"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Wei T, Shi Y. A service failure assessment model for smart product consumption experience based on customer perception. Scientific Reports. 2024; 14: 23097.","DOI":"10.1038\/s41598-024-75283-7"}],"container-title":["Die Pharmazie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/Pharmazie\/81\/6\/10.31083\/Pharmazie52007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T12:57:05Z","timestamp":1783429025000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/Pharmazie\/81\/6\/10.31083\/Pharmazie52007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,28]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"alternative-id":["S0031-7144(26)03154-0"],"URL":"https:\/\/doi.org\/10.31083\/pharmazie52007","relation":{},"ISSN":["0031-7144","3053-691X"],"issn-type":[{"value":"0031-7144","type":"print"},{"value":"3053-691X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,28]]},"article-number":"52007"}}